Follow
Karantanis Dimitrios
Karantanis Dimitrios
PET/CT Imaging Center, Iatropolis, Athens, Greece
Verified email at petct.gr - Homepage
Title
Cited by
Cited by
Year
Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland
D Karantanis, TV Bogsrud, GA Wiseman, BP Mullan, RM Subramaniam, ...
Journal of Nuclear Medicine 48 (6), 896-901, 2007
1712007
The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET–CT
TV Bogsrud, D Karantanis, MA Nathan, BP Mullan, GA Wiseman, ...
Nuclear medicine communications 28 (5), 373-381, 2007
1352007
PET/CT of cancer patients: part 1, pancreatic neoplasms
EH Dibble, D Karantanis, G Mercier, PJ Peller, LA Kachnic, ...
American journal of roentgenology 199 (5), 952-967, 2012
1082012
18F-FDG PET in the management of patients with anaplastic thyroid carcinoma
TV Bogsrud, D Karantanis, MA Nathan, BP Mullan, GA Wiseman, ...
Thyroid 18 (7), 713-719, 2008
882008
The Value of [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Extranodal Natural Killer/T—Cell Lymphoma
D Karantanis, RM Subramaniam, PJ Peller, VJ Lowe, JM Durski, ...
Clinical Lymphoma and Myeloma 8 (2), 94-99, 2008
602008
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients
D Karantanis, BP O'Neill, RM Subramaniam, RJ Witte, BP Mullan, ...
Nuclear medicine communications 28 (11), 834-841, 2007
572007
18F-FDG PET and PET/CT in Burkitt's lymphoma
D Karantanis, JM Durski, VJ Lowe, MA Nathan, BP Mullan, E Georgiou, ...
European journal of radiology 75 (1), e68-e73, 2010
522010
The Prognostic Value of 2-Deoxy-2-[18F]Fluoro-d-Glucose Positron Emission Tomography in Patients With Suspected Residual or Recurrent Medullary Thyroid …
TV Bogsrud, D Karantanis, MA Nathan, BP Mullan, GA Wiseman, ...
Molecular Imaging and Biology 12, 547-553, 2010
392010
Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma
D Karantanis, BP O'Neill, RM Subramaniam, PJ Peller, RJ Witte, ...
Clinical nuclear medicine 32 (4), 271-274, 2007
352007
Hibernoma: 18F FDG PET/CT Imaging
RM Subramaniam, AC Clayton, D Karantanis, DA Collins
Journal of Thoracic Oncology 2 (6), 569-570, 2007
342007
Relationship among glycolytic phenotype, grade, and histological subtype in ovarian carcinoma
D Karantanis, M Allen-Auerbach, J Czernin
Clinical nuclear medicine 37 (1), 49-53, 2012
332012
Focal F-18 fluoro-deoxy-glucose accumulation in the lung parenchyma in the absence of CT abnormality in PET/CT
D Karantanis, RM Subramaniam, BP Mullan, PJ Peller, GA Wiseman
Journal of computer assisted tomography 31 (5), 800-805, 2007
302007
Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodies
TV Bogsrud, ID Hay, D Karantanis, MA Nathan, BP Mullan, GA Wiseman, ...
Nuclear medicine communications 32 (4), 245-251, 2011
252011
Oncologic 18F-FDG PET/CT: referring physicians’ point of view
D Karantanis, D Kalkanis, M Allen-Auerbach, TV Bogsrud, ...
Journal of Nuclear Medicine 53 (10), 1499-1505, 2012
162012
Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physicians
D Karantanis, D Kalkanis, J Czernin, K Herrmann, KL Pomykala, ...
Journal of Nuclear Medicine 55 (12), 1925-1929, 2014
132014
[18F] Fluoro-L-dopa PET/CT in congenital hyperinsulinism
RM Subramaniam, D Karantanis, PJ Peller
Journal of computer assisted tomography 31 (5), 770-772, 2007
62007
18F-FDG PET/CT Imaging of Pulmonary Mucinous Cystadenocarcinoma with Signet Ring Cells
A Kalkanis, L Palaiodimos, I Klinaki, D Karantanis, D Kalkanis
Nuclear Medicine and Molecular Imaging 51, 277-280, 2017
52017
FDG PET in the management of patients with well differentiated thyroid carcinoma and positive thyroglobulin autoantibodies
TV Bogsrud, D Karantanis, MA Nathan, BP Mullan, GA Wiseman, ID Hay, ...
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 34, S122-S122, 2007
32007
Squamous papilloma of the oral cavity and oropharynx on 18F-FDG PET/CT imaging
D Karantanis, M Allen-Auerbach, J Czernin
Clinical Nuclear Medicine 37 (5), e98-e99, 2012
22012
Sources and resources for oncologists to help answer the question: Is PET/CT appropriate for my patient?
MD Dimitrios Karantanis, M Allen-Auerbach, J Czernin
Hell J Nucl Med 15 (1), 2-8, 2012
22012
The system can't perform the operation now. Try again later.
Articles 1–20